Ursonal, Sulpecio P.

HRN: 22-17-13  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/04/2022
11/08/2022
PO
500mg
Od
Cap Mr, T/c Aspiration Pneumonia
Waiting Final Action 
11/04/2022
CEFTRIAXONE 1G (VIAL)
11/04/2022
11/10/2022
IVT
2gms
Od
Cap Mr, T/c Aspiration Pneumonia
Waiting Final Action 
11/07/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/07/2022
11/14/2022
IV
600mg
Q8
Progressing CAP
Waiting Final Action 
11/10/2022
CEFIXIME 200MG (CAP)
11/10/2022
11/16/2022
ORAL
200mg
BID
CVD; CAP HR
Waiting Final Action 
11/21/2022
CEFTAZIDIME 1GM (VIAL)
11/21/2022
11/28/2022
IV
1gm
Q8
Empirical Escalation
Waiting Final Action 
11/23/2022
CEFTAZIDIME 1GM (VIAL)
11/23/2022
11/30/2022
IVTT
2g
Q8
Pulmonary Infection/ Infiltrates
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: